BioXcel Therapeutics Inc - BTAI - stock price prediction, stock price target, analyst ratings from 4 analysts

BioXcel Therapeutics Inc has a share price target of US$ 14, revenue growth forecast of -76.2%, and profit growth estimate of -14.2% for FY25, based on top 4 analyst calls.